archiveBlaise Bratter

Zelda and US company JC Pharma Inc have been granted patents for their novel medicinal cannabis technologies.

ASX medical cannabis companies show their financial standing in their recently published half-yearly reports.

Botanix is currently running medicinal cannabis Phase 2 clinical trials on acne and atopic dermatitis, and Phase 1B on psoriasis.

With the supply of a 1:1 capsule for a clinical trial on Tourette's Syndrome.

Patients can now register with the FDA for legal possession without being punished.

Growing evidence of THC as a treatment option for HER2+ breast cancer.

The 2-minute commercial is part of MedMens 'The New Normal' marketing campaign.

MGC Pharmaceuticals (ASX: MXC) (OTC: MGCLF) has announced confirmation that...

AusCann (ASX: AC8) has announced the appointment of Mr Ido...